These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8478313)

  • 1. Pharmacokinetics of dirithromycin.
    Sides GD; Cerimele BJ; Black HR; Busch U; DeSante KA
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():65-75. PubMed ID: 8478313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue distribution of dirithromycin: comparison with erythromycin.
    Bergogne-Bérézin E
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():77-87. PubMed ID: 8478314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics of dirithromycin and erythromycin in normal volunteers with special regard to accumulation in polymorphonuclear leukocytes and in saliva.
    Geerdes-Fenge HF; Goetschi B; Rau M; Borner K; Koeppe P; Wettich K; Lode H
    Eur J Clin Pharmacol; 1997; 53(2):127-33. PubMed ID: 9403284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New drugs--reports of new drugs recently approved by the FDA. Dirithromycin.
    Shinkai I; Ohta Y
    Bioorg Med Chem; 1996 Apr; 4(4):521-2. PubMed ID: 8735838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug interactions of macrolides: emphasis on dirithromycin.
    Watkins VS; Polk RE; Stotka JL
    Ann Pharmacother; 1997 Mar; 31(3):349-56. PubMed ID: 9066944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tonsillar tissue penetration of dirithromycin after multiple doses.
    Benson JM; Arnold J; Manning SC; Coleman DL; Sides GD; Conforti PM; Lemon E; Watkins VS
    J Clin Pharmacol; 1996 Sep; 36(9):832-7. PubMed ID: 8889904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dirithromycin and erythromycylamine on human neutrophil degranulation.
    Abdelghaffar H; Mtairag EM; Labro MT
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1548-54. PubMed ID: 7979287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of dirithromycin in patients with impaired hepatic function.
    LaBreque D; Johlin F; Janda R; Shreves T; Gereats D; DeSante K; Cerimele B; Lanier T; Sides G
    J Antimicrob Chemother; 1993 Nov; 32(5):741-50. PubMed ID: 8125838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dirithromycin: a new macrolide.
    Wintermeyer SM; Abdel-Rahman SM; Nahata MC
    Ann Pharmacother; 1996 Oct; 30(10):1141-9. PubMed ID: 8893122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dirithromycin on human CYP3A in vitro and on pharmacokinetics and pharmacodynamics of terfenadine in vivo.
    Goldberg MJ; Ring B; DeSante K; Cerimele B; Hatcher B; Sides G; Wrighton S
    J Clin Pharmacol; 1996 Dec; 36(12):1154-60. PubMed ID: 9013373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steady-state pharmacokinetics of theophylline in COPD patients treated with dirithromycin.
    Bachmann K; Jauregui L; Sides G; Sullivan TJ
    J Clin Pharmacol; 1993 Sep; 33(9):861-5. PubMed ID: 8227485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
    Setnikar I; Rovati LC
    Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the steady-state pharmacokinetics of theophylline during treatment with dirithromycin.
    Bachmann K; Nunlee M; Martin M; Sullivan T; Jauregui L; DeSante K; Sides GD
    J Clin Pharmacol; 1990 Nov; 30(11):1001-5. PubMed ID: 2243147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antimicrobial evaluation of dirithromycin (AS-E 136; LY237216), a new macrolide antibiotic derived from erythromycin.
    Counter FT; Ensminger PW; Preston DA; Wu CY; Greene JM; Felty-Duckworth AM; Paschal JW; Kirst HA
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1116-26. PubMed ID: 1929252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of dirithromycin and erythromycylamine uptake by human neutrophils in vitro.
    Mtairag EM; Abdelghaffar H; Labro MT
    J Antimicrob Chemother; 1994 Mar; 33(3):523-36. PubMed ID: 8040116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dirithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.
    Brogden RN; Peters DH
    Drugs; 1994 Oct; 48(4):599-616. PubMed ID: 7528132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of dirithromycin in patients with mild or moderate cirrhosis.
    Mazzei T; Surrenti C; Novelli A; Biagini MR; Fallani S; Cassetta MI; Conti S; Surrenti E
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1556-9. PubMed ID: 10390202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro interaction between dirithromycin or its metabolite, erythromycylamine, and oxidative polymorphonuclear metabolism.
    Moutard I; Gressier B; Brunet C; Dine T; Luyckx M; Cazin M; Cazin JC
    J Antibiot (Tokyo); 1997 Jan; 50(1):53-7. PubMed ID: 9066766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the interaction between dirithromycin and astemizole in healthy adults.
    Bachmann K; Sullivan TJ; Reese JH; Jauregui L; Miller K; Scott M; Stotka J; Harris J
    Am J Ther; 1997; 4(2-3):73-9. PubMed ID: 10423595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models.
    Montenez JP; Van Bambeke F; Piret J; Brasseur R; Tulkens PM; Mingeot-Leclercq MP
    Toxicol Appl Pharmacol; 1999 Apr; 156(2):129-40. PubMed ID: 10198278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.